Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01037751 · ClinicalTrials.gov registry record
M. D. Anderson Symptom Inventory - Ovarian Cancer
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 158
- Enrollment target
NCT01037751: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT01037751 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 158 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01037751 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 158 participants
- Enrollment target
Study Summary
Objectives: The objective of this study is to delineate and measure the symptom burden experienced by patients with ovarian cancer. The Primary Aim is to develop and validate an ovarian-cancer module of the M. D. Anderson Symptom Inventory (MDASI-Ovarian Cancer) to measure the severity of multiple symptoms and the impact of these symptoms on daily functioning in patients with ovarian cancers. The Secondary Aims are: To develop a detailed description of symptom severity and interference with daily activities experienced by patients with ovarian cancer; To assess the impact of symptom severity on standard functioning and quality of life (QOL) measures, including Eastern Cooperative Oncology Group Performance Status (ECOG PS), Functional Assessment of Cancer Therapy-Ovary (FACT-O), and a single-item QOL scale, in patients with ovarian cancer; To define the qualitative symptom burden of patients with ovarian cancer receiving various treatments.
Interventions
- BEHAVIORAL Survey
- BEHAVIORAL Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2009-12-30 |
| Est. Completion | 2018-07-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01037751
The ClinicalTrials.gov registry entry for NCT01037751 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 158 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Survey is the first listed.
NCT01037751 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01037751 about?
NCT01037751 is a clinical study titled "M. D. Anderson Symptom Inventory - Ovarian Cancer". Objectives: The objective of this study is to delineate and measure the symptom burden experienced by patients with ovarian cancer. The Primary Aim is to develop and validate an ovarian-cancer module of the M. D. Anderson Symptom Inventory (MDASI-Ovarian Cancer) to measure the severity of multiple...
What is the current status of trial NCT01037751?
This trial is currently completed. The enrollment target is 158 participants. The study started on 2009-12-30. Estimated completion is 2018-07-18.
What interventions are being tested in trial NCT01037751?
The interventions under investigation include: Survey (BEHAVIORAL), Interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT01037751?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.